HLS THERAPEUTICS INC

No trades
See on Supercharts
Market capitalization
110.323MCAD
−1.19CAD
−30.721MCAD
80.021MCAD
Beta
0.29

About HLS THERAPEUTICS INC

CEO
Craig Millian
Headquarters
Etobicoke
Employees (FY)
99
Founded
2014
ISIN
CA40390B1094
HLS Therapeutics, Inc. operates as a pharmaceutical company. It focuses on clinically differentiated pharmaceutical products in the specialty central nervous system (CNS) and cardiovascular (CV) markets. The company was founded by Gregory Gubitz and Gilbert Godin on March 12, 2018 and is headquartered in Etobicoke, Canada.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Performance
Revenue to profit conversion
Earnings
‪0‬
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good

See all brokers